Clinical Trials | May 08, 2026
Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial
NEJM study shows strong protection across strains
NEJM study shows strong protection across strains
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
Approval strengthens the company’s growing international anti-infective portfolio
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
